Wantai Biotech Investor Relations Management System (Revised in November 2025)
Beijing Wantai Biopharmaceutical Co., Ltd. Investor Relations Management System Beijing Wantai Biopharmaceutical Co., Ltd. Investor Relations Management System
November 2025
Beijing Wantai Biopharmaceutical Co., Ltd. Investor Relations Management System
Beijing Wantai Biopharmaceutical Co., Ltd.
Investor Relations Management System
(Revised in November 2025)
Chapter 1 General Provisions
Article 1 In order to further improve the governance structure of Beijing Wantai Biopharmaceutical Co., Ltd. (hereinafter referred to as the "Company"), standardize the company's investor relations work, strengthen communication between the company and investors, deepen investors' understanding and recognition of the company, promote long-term, stable and good relationships between the company and investors, enhance the company's integrity, core competitiveness and sustainable development capabilities, and maximize the company's value In order to maximize the interests of shareholders and the Company Law of the People's Republic of China (hereinafter referred to as the "Company Law"), the Securities Law of the People's Republic of China (hereinafter referred to as the "Securities Law") and other laws, regulations, rules, normative documents and the Articles of Association of Beijing Wantai Biopharmaceutical Co., Ltd. (hereinafter referred to as the "Articles of Association"), this system is formulated based on the actual situation of the company.
Article 2 Investor relations work refers to relevant activities in which listed companies strengthen communication with investors and potential investors by facilitating the exercise of shareholders' rights, information disclosure, interactive communication, and handling of complaints, and enhance investors' understanding and recognition of listed companies, so as to improve the governance level of listed companies and the overall value of the enterprise, and achieve the purpose of respecting investors, rewarding investors, and protecting investors.
Article 3 Investor relations work shall strictly abide by the Company Law, Securities Law and other relevant laws, regulations and the provisions of the securities regulatory authorities.
Article 4 Investor relations management work should reflect the principles of fairness, impartiality and openness, treat all investors equally, and ensure that all investors enjoy the right to know and other legitimate rights and interests.
Chapter 2 The Purpose, Principles and Content of Investor Relations Work
Article 5 The purpose of investor relations management is to:
(1) Promote a healthy relationship between the company and investors and enhance investors’ further understanding and familiarity with the company;
(2) Establish a stable and high-quality investor base and obtain long-term market support;
(3) Form a corporate culture that serves investors and respects investors;
(4) An investment philosophy that promotes the maximization of the company’s overall interests and the growth of shareholders’ wealth;
(5) Increase the transparency of company information disclosure and improve corporate governance.
Article 6 The basic principles of investor relations work are:
Beijing Wantai Biopharmaceutical Co., Ltd. Investor Relations Management System
(1) Principle of compliance. The investor relations management of listed companies should be carried out on the basis of fulfilling information disclosure obligations in accordance with the law, and in compliance with laws, regulations, rules and normative documents, industry norms and self-discipline rules, internal company rules and regulations, as well as ethics and codes of conduct generally observed by the industry.
(2) The principle of equality. When listed companies carry out investor relations management activities, they should treat all investors equally, especially create opportunities and provide convenience for small and medium-sized investors to participate in activities.
(3) The principle of initiative. Listed companies should proactively carry out investor relations management activities, listen to investors’ opinions and suggestions, and respond to investor demands in a timely manner.
(4) The principle of honesty and trustworthiness. Listed companies should pay attention to integrity, adhere to the bottom line, standardize operations, assume responsibilities in investor relations management activities, and create a healthy and good market ecology.
Article 7 The content of communication between the company and investors in investor relations work mainly includes:
(1) The company’s development strategy;
(2) Legal information disclosure content;
(3) The company’s operation and management information;
(4) The company’s environmental, social and governance information;
(5) Company culture construction;
(6) Methods, channels and procedures for exercising shareholders’ rights;
(7) Information on handling investor complaints;
(8) Risks and challenges that the company is facing or may face;
(9) Other relevant information of the company.
Chapter 3 Investor Relations Activities
Section 1 Shareholders Meeting
Article 8 The company shall conscientiously arrange and organize the shareholders’ meeting in accordance with the requirements of laws and regulations.
Article 9 The company should strive to create conditions for small and medium-sized shareholders to participate in the shareholders' meeting, fully consider the time and place of the meeting to facilitate shareholders' participation, and provide necessary time for investors to communicate with the company's directors and senior managers.
Section 2 Website
Article 10 The company shall publish the website address in periodic reports in accordance with regulations. When the website address changes, the company should promptly announce the changed website address.
Article 11 The company should update the company website in a timely manner and display historical information and current information in order to display the Investor Relations Management System of Beijing Wantai Biopharmaceutical Co., Ltd.
Labels should be used to distinguish them, and erroneous information should be corrected in a timely manner to avoid misleading investors.
Article 12 The company shall establish its official website and set up an investor relations column on the website to collect and respond to investors’ questions and suggestions, and timely release and update information related to investor relations management.
Section 3 Analyst meetings, performance briefings and road shows
Article 13 The company may hold analyst meetings, performance briefings or road shows after the completion of regular reports, when implementing financing plans or when the company deems necessary.
Article 14 Analyst meetings, performance briefings and roadshows shall be conducted in as public a manner as possible, and may be broadcast live online if conditions permit.
Article 15 If analyst meetings, performance briefings or roadshows are broadcast online, investors may be notified publicly in advance of the meeting time, login website and login method, etc.
Article 16 The company may collect relevant questions from small and medium-sized investors in advance through e-mails, online forums, phone calls, letters, etc., and respond to them through the Internet at analyst meetings, performance briefings and road shows.
Article 17 Analyst meetings or performance briefings can be interactive online. Investors can directly ask questions online, and companies can also directly answer relevant questions online.
Article 18 If analyst meetings, performance briefings or roadshows cannot be broadcast live online, the company can invite reporters from the news media to participate and make objective reports.
Article 19 The company may place video materials of analyst meetings, performance briefings and roadshows on the company website for investors to view at any time. If the conditions are not met, the company can place text materials about analyst meetings or performance briefings on the company's website for investors to view.
Article 20 If a company's relevant major matters are highly concerned or questioned by the market, in addition to fulfilling its information disclosure obligations in a timely manner in accordance with the listing rules, it should also hold a briefing meeting on site, online or through other means to introduce the situation, explain the reasons, and answer relevant questions. The company's chairman of the board, general manager, secretary of the board of directors, financial controller or other responsible persons should attend the briefing.
Article 21 If the company's annual net profit drops significantly compared with the previous year or it has the ability to pay dividends but the level of dividends is low, and the above situations are highly concerned or questioned by the market, it may hold online, offline or other forms of road shows.
Article 22 When a company encounters the following circumstances, it shall hold an investor briefing meeting in accordance with the regulations of the China Securities Regulatory Commission and the stock exchange:
Beijing Wantai Biopharmaceutical Co., Ltd. Investor Relations Management System
(1) The company’s cash dividend level for the current year does not meet relevant regulations, and the reasons need to be explained;
(2) The company terminates its reorganization after disclosing its reorganization plan or reorganization report;
(3) The company's securities transactions experience abnormal fluctuations stipulated in relevant rules, and the company finds after verification that there are major undisclosed events;
(4) Major events related to the company have received high attention or doubts from the market;
(5) Other situations where investor briefings should be held.
Section 4 One-on-one communication
Article 23 The company may, when deemed necessary, conduct one-on-one communications with investors, fund managers, analysts, etc. regarding the company's operating conditions, financial status and other matters, introduce the company's situation, answer relevant questions and listen to relevant suggestions.
Article 24 In one-on-one communication, the company should treat investors equally and create opportunities for small and medium-sized investors to participate in one-on-one communication activities.
Article 25 In order to avoid possible selective information disclosure during one-to-one communication, the company can publish relevant audio, video and written records of one-to-one communication on the company website, and can also invite news organizations to participate in one-on-one communication activities and report on them.
Section 5 On-site visit
Article 26 The company may try its best to arrange for investors, analysts and fund managers to visit the company or the location of the fund-raising project for on-site visits.
Article 27 The company should provide convenience for small and medium-sized shareholders to visit the company’s site, hold discussions and communicate, and arrange visits and hold discussions reasonably and properly.
Article 28 The company should arrange the visit process reasonably and properly to enable visitors to understand the company's business and operating conditions, and at the same time, care should be taken to avoid giving visitors the opportunity to obtain important undisclosed information during the visit.
Article 29 The company must provide necessary training and guidance on investor relations and information disclosure to relevant reception personnel in advance.
Article 30 When a company accepts research from institutions and individuals engaged in securities analysis, consulting and other securities services, as well as institutions and individuals engaged in securities investment, it shall properly carry out relevant reception work and perform corresponding information disclosure obligations in accordance with regulations. Companies, research institutions and individuals are not allowed to use research activities to engage in market manipulation, insider trading or other illegal activities.
Section 6 Telephone Consultation
Article 31 The company should set up a special investor consultation hotline, and investors can use the consultation hotline Beijing Wantai Biopharmaceutical Co., Ltd. Investor Relations Management System
Ask the company about its concerns.
Article 32 There should be a dedicated person in charge of the consultation phone to ensure that the phone is answered by a dedicated person during working hours and the line is open, and the relevant information should be answered and fed back to investors in an effective form. In the event of major events or other necessary times, the company should open multiple telephone numbers to answer investor inquiries.
Article 33 The company shall publish the consultation telephone number in the periodic report. Any changes must be announced on the company website as soon as possible and disclosed in a formal announcement in a timely manner.
Article 34 The company may set up a public e-mail box to communicate with investors. Investors can ask questions and understand the situation to the company through e-mail, and the company can also reply or answer relevant questions through e-mail.
Article 35 Listed companies shall ensure that external communication channels such as consultation telephones, faxes, and e-mails are open. The company's replies and feedback to investors through the above channels should be disclosed at least quarterly.
Chapter 4 Organization and Implementation of Investor Relations Work
Article 36 Investor relations work is led by the chairman of the board, and the secretary of the board of directors serves as the person in charge of investor relations and is responsible for the company’s investor relations work. The company's board of directors office is the company's investor relations management department.
Article 37 The person in charge of investor relations shall be responsible for planning, arranging and organizing various investor relations management activities with a comprehensive and in-depth understanding of the company's operations and management, business conditions, development strategies, etc.
Article 38 The person in charge of investor relations is responsible for formulating the work management methods and implementation details of the company’s investor relations management, and is responsible for the specific implementation and implementation.
Article 39 The person in charge of investor relations is responsible for conducting comprehensive and systematic training on investor relations management for the company’s directors, senior managers and relevant personnel.
Article 40 Before conducting investor relations activities, the person in charge of investor relations may adopt appropriate methods to provide targeted training and guidance to the company’s senior managers and relevant personnel.
Article 41 The person in charge of investor relations should continue to pay attention to various information about the company in the news media and the Internet and provide timely feedback to the company's board of directors and management.
Article 42 The company’s personnel engaged in investor relations work need to possess the following qualities and skills:
(1) Comprehensively understand all aspects of the company;
(2) Have a good knowledge structure and be familiar with corporate governance, financial accounting and other relevant laws and regulations and the operating mechanisms of the securities market;
Beijing Wantai Biopharmaceutical Co., Ltd. Investor Relations Management System
(3) Have good communication and coordination skills;
(4) Have good conduct and be honest and trustworthy.
Article 43 The main responsibilities of investor relations management include:
(1) Formulate an investor relations management system and establish a working mechanism;
(2) Organize investor relations management activities to communicate with investors;
(3) Organize timely and appropriate handling of investor inquiries, complaints, suggestions and other demands, and provide regular feedback to the company's board of directors and management;
(4) Manage, operate and maintain relevant channels and platforms for investor relations management;
(5) Ensure investors exercise their shareholder rights in accordance with the law;
(6) Cooperate and support investor protection agencies in carrying out relevant work to safeguard the legitimate rights and interests of investors;
(7) Statistically analyze the number, composition and changes of the company’s investors;
(8) Carry out other activities that are conducive to improving investor relations.
Article 44 The company should establish a good internal coordination mechanism and information collection system. The departments or personnel responsible for investor relations should promptly collect production, operation, financial, litigation and other information of various departments and subordinate companies, and all departments and subordinate companies of the company should actively cooperate.
Article 45 Unless expressly authorized, senior managers and other employees of the company are not allowed to speak on behalf of the company in investor relations activities.
Article 46 The company may adopt appropriate methods to provide training on investor relations work to all employees, especially senior managers and heads of relevant departments. Special training can also be provided when carrying out major investor relations promotion activities.
Article 47 If the company deems it necessary and conditional, it may hire professional investor relations consultants to consult, plan and handle investor relations, including media relations, development strategies, investor relations management training, crisis management, analyst meetings and performance briefing arrangements, etc.
Article 48 A company shall not engage in the following situations in its investor relations management work:
(1) Disclose or publish information about major events that have not yet been made public, or information that conflicts with information disclosed in accordance with the law;
(2) Disclose or publish misleading, false or exaggerated information;
(3) Selective disclosure or release of information, or major omissions
(4) Making public expectations or commitments regarding the company’s securities prices;
(5) Speak on behalf of the company without explicit authorization;
(6) Discrimination, contempt and other unfair treatment of small and medium-sized shareholders or unfair disclosure;
(7) Violating public order and good customs and harming social and public interests;
Beijing Wantai Biopharmaceutical Co., Ltd. Investor Relations Management System
(8) Other violations of information disclosure rules or suspected manipulation of stock prices.
Chapter 5 Supplementary Provisions
Article 49 This system will take effect after being reviewed and approved by the company's board of directors.
Article 50 Matters not covered by this system shall be governed by the relevant national laws, regulations, normative documents and the "Articles of Association"; if this system conflicts with national laws, regulations, normative documents or the "Articles of Association", the provisions of the relevant national laws, regulations, normative documents and the "Articles of Association" shall be implemented.
Article 51 The board of directors is responsible for interpreting this system.